JP2000204077A5 - - Google Patents

Download PDF

Info

Publication number
JP2000204077A5
JP2000204077A5 JP1999053564A JP5356499A JP2000204077A5 JP 2000204077 A5 JP2000204077 A5 JP 2000204077A5 JP 1999053564 A JP1999053564 A JP 1999053564A JP 5356499 A JP5356499 A JP 5356499A JP 2000204077 A5 JP2000204077 A5 JP 2000204077A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
iodo
phenylamino
difluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1999053564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000204077A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2000204077A publication Critical patent/JP2000204077A/ja
Publication of JP2000204077A5 publication Critical patent/JP2000204077A5/ja
Abandoned legal-status Critical Current

Links

JP11053564A 1999-01-13 1999-03-02 ジアリ―ルアミン Abandoned JP2000204077A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11587599P 1999-01-13 1999-01-13
US115875 1999-01-13

Publications (2)

Publication Number Publication Date
JP2000204077A JP2000204077A (ja) 2000-07-25
JP2000204077A5 true JP2000204077A5 (https=) 2006-04-27

Family

ID=22363910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11053564A Abandoned JP2000204077A (ja) 1999-01-13 1999-03-02 ジアリ―ルアミン

Country Status (3)

Country Link
JP (1) JP2000204077A (https=)
UA (1) UA72239C2 (https=)
ZA (1) ZA200105219B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE480527T1 (de) 2001-12-11 2010-09-15 Kyowa Hakko Kirin Co Ltd Thiadiazolinderivate zur krebsbehandlung
SG2013013339A (en) 2002-03-13 2014-12-30 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
CA2522594C (en) 2003-04-18 2012-01-24 Kyowa Hakko Kogyo Co., Ltd. Mitotic kinesin inhibitor
EP1908755A4 (en) 2005-06-24 2009-06-24 Kyowa Hakko Kirin Co Ltd THERAPEUTIC AGENT AGAINST RESTENOSIS
EP2370568B1 (en) 2008-12-10 2017-07-19 Dana-Farber Cancer Institute, Inc. Mek mutations conferring resistance to mek inhibitors
NZ601408A (en) 2009-12-25 2013-12-20 Mochida Pharm Co Ltd Novel 3-hydroxy-5-arylisothiazole derivative
EP3028699B1 (en) 2010-02-25 2018-03-21 Dana-Farber Cancer Institute, Inc. Braf mutations conferring resistance to braf inhibitors
CN103038364A (zh) 2010-03-09 2013-04-10 达纳-法伯癌症研究所公司 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
BR112013027883A2 (pt) 2011-04-27 2017-08-08 Mochida Pharm Co Ltd novo derivado de 1-óxido de 3-hidroxiisotiazol
US20150141470A1 (en) 2012-05-08 2015-05-21 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy

Similar Documents

Publication Publication Date Title
JP2002534515A5 (https=)
JP2000204077A5 (https=)
RU99119545A (ru) Производные дитиолана, лекарственные средства
RU2506267C2 (ru) Бензопирановые и бензоксепиновые ингибиторы рi3k и их применение
RU2002133666A (ru) Производные триазола
RU2007139634A (ru) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
RU2008140940A (ru) Производное триазола или его соль
RU2501791C2 (ru) Производное триазола или его соль
JP2008501018A5 (https=)
JP2007502806A5 (https=)
JP2004520292A5 (https=)
RU96116158A (ru) Замещенные производные морфолина и их применение в качестве терапевтических агентов
JP2004532209A5 (https=)
JP2006511612A5 (https=)
EP2179987A3 (en) Use of heterocyclic carbaldehyde derivatives against sickle cell anemia
JP2006077019A5 (https=)
JP2008517976A5 (https=)
JP2004517087A5 (https=)
JP2010519304A5 (https=)
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
JP2001526218A5 (https=)
JP2018503661A5 (https=)
JP2009501775A5 (https=)
JP2004521150A5 (https=)
JP2008535803A5 (https=)